Antineoplastic, tyrosine kinase inhibitor used for the treatment of patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).(Ph+ CML).
Regitrat
Antineoplastic, EGFR tyrosine kinase inhibitor. Indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring activating EGFR mutations (Del19, L858R, and other less common mutations).
Brocabe
Bruton’s tyrosine kinase inhibitor, oral antineoplastic. Indicated for the treatment of oncohematologic neoplasms (chronic lymphocytic leukemia, mantle cell lymphoma, marginal zone lymphoma), Waldenström’s macroglobulinemia, and graft-versus-host disease.
Novex
Antineoplastic. Anti CD20 monoclonal antibody indicated to treat oncohematologic neoplasms such as Non Hodgkin Lymfom, chronic Lymphocytic Leukemia. Rheumatoid arthritis treatment.
Alcaf
Antineoplastic. Proteasome inhibitor. Indicated to treat multiple myeloma.
